Scientists in the US have developed a new test for Parkinson’s disease, which has the potential to revolutionize the way that the illness is diagnosed and treated. Parkinson’s is characterized by the build-up of a protein called alpha-synuclein in the brain. The new test, which accurately measures the levels of this protein, was tried out on more than 1,000 participants, including those who had already been diagnosed with Parkinson’s disease, and those who were considered to be at risk of the disease. Experts hope that the development of such a test could lead to earlier diagnosis, more tailored treatment for patients and a search for a cure.
Today: December 10, 2023